any t/o would obviously not be from competitors, but aside from private equity I suppose it's possible that a major health care co (eg johnson and johnson or other medical companies) might be keen to get into the sector.
They are however probably more conservative than private equity and RMD is priced for growth.
takeover target, page-8
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.66 |
Change
-0.940(2.50%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $36.32 | $36.69 | $36.13 | $46.16M | 1.265M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13944 | $36.66 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.71 | 12610 | 4 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
